|
|
Volumn 30, Issue 8, 2004, Pages 711-713
|
|
Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
ADULT;
AGED;
ALOPECIA;
ANALYTIC METHOD;
ANALYTICAL ERROR;
ANEMIA;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLON CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG HYPERSENSITIVITY;
EVIDENCE BASED MEDICINE;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
INFECTION;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
NEUTROPENIA;
PARESTHESIA;
PHLEBITIS;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SKIN TOXICITY;
STOMATITIS;
THROMBOCYTOPENIA;
THROMBOSIS;
VOMITING;
|
|
EID: 8744226109
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ctrv.2004.09.002 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
